ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary Mediastinal B-Cell Lymphoma Patients with CR to Standard Immunochemotherapy: The IELSG37 Randomized Trial"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary Mediastinal B-Cell Lymphoma Patients with CR to Standard Immunochemotherapy: The IELSG37 Randomized Trial"

By ecancer FEATURING Emanuele Zucca

187 views

June 14, 2023

0 Comments

Treatment-Related Quality of Life in MF

Feat. A. Hunter

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…

06:09

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Outcomes of Pts With Richter's Transfo…

Feat. A. Kittai

35:24

SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: Aggressive B-Cell Lymphomas

Feat. G. Nowakowski

15:28

SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Treatment Options for Primary Mediastinal B-Cell Lymphoma

Feat. K. Dunleavy

08:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Phase 2 KEYNOTE-B68 Trial - Efficacy …

Feat. A. Mcdonald

18:10

SOHO Turkey 2023

SOHO Turkey 2023: DLBCL Management

Feat. I. Barista

02:27

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Efficacy of Mosunetuzumab Monotherapy in Pa…

Feat. C. Cheah

05:13

ASCO 2022 Conference Coverage

ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Eff…

Feat. R. Steiner

02:39

ecancer

ASCO® 2023 Insights: "ZUMA-7 Study Summary - Axi-Cel in Early R…

Feat. J. Westin

05:45

Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Anti-CD19 CAR T-Cell Therapy for Richter&#x…

Feat. A. Kittai

25:46

SOHO Highlights: State of the Art and Next Questions

SOHO Highlights - State of the Art & Next Questions: Aggressive …

Feat. L. Sehn

15:35

2021 Virtual ESMO Review

ESMO 2021 Highlights on Lymphomas: R/R Marginal Zone Lymphoma, PMLBC…

Feat. J. Vose

19:21

2021 Virtual ESMO Review

ESMO 2021 Hematologic Malignancies Panel Discussion

Feat. J. Vose, H. Erba

18:23

VCU Massey Cancer Center

VCU Health Updates on Extranodal Lymphomas

Feat. V. Yazbeck

11:04

UChicago Medicine

UChicago Medicine Lymphoma Updates: Experts Review the Session on th…

Feat. S. Smith, T. Fenske, A. Evens

18:24

SOHO 2022 Tenth Annual Meeting

SOHO 2022: Challenging Cases in Rare T-Cell Lymphomas

Feat. S. Barta

10:34

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in Aggressive B-Cell Lymphoma

Feat. G. Nowakowski

15:58

Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Updates on Primary Mediastinal B-Cell Lymphoma: Surveying …

Feat. K. Dunleavy

15:50

Indy Hematology Review

Treatment Algorithm for DLBCL

Feat. J. Leonard

20:32

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis …

Feat. S. Kalayoglu Besisik

Login

Login

Join VuMedi

ASCO® 2023 Insights: "Observation Vs. Radiotherapy in Primary Mediastinal B-Cell Lymphoma Patients with CR to Standard Immunochemotherapy: The IELSG37 Randomized Trial"

Related Content